Miplyffa

Active Ingredient(s): Arimoclomol Citrate
FDA Approved: * September 20, 2024
Pharm Company: * ZEVRA DENMARK AS
Category: Genetic Disorders
* May have multiple approval dates, manufacturers, or labelers.